癌症（英文版）2017，Vol.36Issue(12)：677-685,9.
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer:a multicenter,randomized,double-blinded,placebo-controlled,phaseⅡclinical trial
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer:a multicenter,randomized,double-blinded,placebo-controlled,phaseⅡclinical trial
Rui-Hua Xu 1Chang-Ping Wu 2Jin Li 3Yun-Peng Liu 4Dong Wang 5Yi Ba 6Jue-Ping Feng 7Yu-Xian Bai 8Jing-Wang Bi 9Li-Wen Ma 10Jian Lei 11Lin Shen 12Qing Yang 13Hao Yu 14Ke-Ming Wang 15Gang Wu 16Chun-Mei Shi 17Ke-Feng Ding 18Li-Zhu Lin 19Jin-Wan Wang 20Jian-Ping Xiong21
作者信息
- 1. Department of Medical Oncology,Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Guangzhou 510060,Guangdong,P.R.China
- 2. Department of Medical Oncology,First People's Hospital of Changzhou,Changzhou 213003,Jiangsu,P.R.China
- 3. Department of Medical Oncology,Fudan University Cancer Hospital,Shanghai 200032,P.R.China
- 4. Department of Medical Oncology,First Hospital of China Medical University,Shen-yang 110001,Liaoning,P.R.China
- 5. Cancer Center,Daping Hospital and Insti-tute of Surgery Research,Third Military Medical University,Chongqing 400042,P.R.China
- 6. Department of Gastrointestinal Medical Oncology,Tianjin Medical University Cancer Institute and Hospital,Tianjin 300060,P.R.China
- 7. Depart-ment of Oncology,PuAi Hospital of Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430032,Hubei,P.R.China
- 8. Department of Medical Oncology,Harbin Medical University Cancer Hospital,Harbin 150081,Heilongjiang,P.R.China
- 9. Department of Oncology,Jinan Military General Hos-pital,Jinan 250000,Shandong,P.R.China
- 10. Department of Tumor Chemother-apy and Radiology,Peking University Third Hospital,Beijing 100191,P.R.China
- 11. Department of Gastrointestinal Surgery,First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,Guangdong,P.R.China
- 12. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education),Department of Gastrointestinal Oncology,Peking University Cancer Hospital& Institute,No 52,Fucheng Road,Haidian District,Beijing 100142,P.R.China
- 13. Department of Clinical Medicine,Jiangsu Hengrui Medicine Co.,Ltd,Lianyungang 222047,Jiangsu,P.R.China
- 14. Department of Epidemic and Health Statistics,Nanjing Medical University,Nanjing 211166,Jiangsu,P.R.China
- 15. Department of Medical Oncology,Second Affiliated Hospital of Nanjing Medical University,Nanjing 210011,Jiangsu,P.R.China
- 16. Cancer Center of Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,Hubei,P.R.China
- 17. Department of Medical Oncology,Fujian Medical University Union Hospital,Fuzhou 350001,Fujian,P.R.China
- 18. Department of Surgical Oncology,Second Hospital Affiliated to Zhejiang University School of Medicine,Hangzhou 310009,Zhejiang,P.R.China
- 19. Department of Oncology,First Affiliated Hospital of Guangzhou Medical University of Chinese Medicine,Guangzhou 510405,Guangdong,P.R.China
- 20. Department of Medical Oncology,Chinese Academy of Medical Sciences Cancer Hospital,Beijing 100021,P.R.China
- 21. Department of Medical Oncology,First Affiliated Hospital of Nanchang University,Nanchang 330006,Jiangxi,P.R.China
- 折叠
摘要
关键词
Colorectal cancer/Famitinib/Efficacy/SafetyKey words
Colorectal cancer/Famitinib/Efficacy/Safety引用本文复制引用
Rui-Hua Xu,Chang-Ping Wu,Jin Li,Yun-Peng Liu,Dong Wang,Yi Ba,Jue-Ping Feng,Yu-Xian Bai,Jing-Wang Bi,Li-Wen Ma,Jian Lei,Lin Shen,Qing Yang,Hao Yu,Ke-Ming Wang,Gang Wu,Chun-Mei Shi,Ke-Feng Ding,Li-Zhu Lin,Jin-Wan Wang,Jian-Ping Xiong..Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer:a multicenter,randomized,double-blinded,placebo-controlled,phaseⅡclinical trial[J].癌症（英文版）,2017,36(12):677-685,9.
